Alps Group Inc
ALPS Nasdaq Services-Health Services Financials FY2024–FY2026
What Alps Group Inc does
No business description yet.
- Legal name
- Alps Group Inc
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 20-F · Aug 6, 2026
- Accession · CIK
- 0001493152-26-036364
0002025774
Revenue and margins
Alps Group Inc had $4.9M of revenue in fiscal 2026, up 44.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$2.6M in fiscal 2026, −54.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Alps Group Inc returned — to shareholders in fiscal 2026. The diluted share count rose 1.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Alps Group Inc can carry it.
| Fiscal year end | FY24 | FY25 | FY26 |
|---|---|---|---|
| Cash and short-term investments | $0.5M | $0.3M | $0.6M |
| Interest coverage | −55.0x | −51.4x | −40.2x |
| Current ratio | — | 0.2x | 0.4x |
| Quick ratio | — | 0.1x | 0.3x |
| Total assets | — | $7.1M | $7.0M |
| Total liabilities | — | $8.2M | $10.2M |
| Shareholders' equity | $1.5M | −$0.9M | −$2.9M |
| Net debt (− = net cash) | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ |
| Cash from operations is positive | ✕ | ✕ | ✕ |
| Return on assets rose | — | — | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✕ |
| Debt fell relative to assets | — | — | — |
| Current ratio rose | — | — | ✓ |
| Share count didn't rise | — | ✓ | ✕ |
| Gross margin rose | — | ✓ | ✕ |
| Revenue rose relative to assets | — | — | ✓ |
| F-score | — / 3 | — / 5 | 3 / 8 |
| Accruals ratio | — | −12.7% | 8.0% |
| Altman Z'' | — | −13.07 | −11.72 |
3 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY24 | FY25 | FY26 |
|---|---|---|---|
| Income statement | |||
| Revenue | $2.4M | $3.4M | $4.9M |
| Gross profit | $0.6M | $1.3M | $1.6M |
| Operating income | −$2.4M | −$2.5M | −$2.0M |
| Interest expense | $0.0M | $0.0M | $0.1M |
| Pretax income | −$2.4M | −$2.5M | −$2.1M |
| Income tax | −$0.0M | $0.1M | $0.0M |
| Net income | −$2.3M | −$2.5M | −$2.0M |
| Net income to common | −$2.3M | −$2.5M | −$2.0M |
| Diluted EPS | −$0.01 | −$0.02 | −$0.02 |
| Diluted shares | 0.16B | 0.16B | 0.16B |
| Cash flow | |||
| Cash from operations | −$1.4M | −$1.6M | −$2.6M |
| Capital expenditure | $0.2M | $0.1M | $0.1M |
| Free cash flow | −$1.6M | −$1.7M | −$2.6M |
| Balance sheet | |||
| Cash and short-term investments | $0.5M | $0.3M | $0.6M |
| Current assets | — | $1.5M | $2.0M |
| Current liabilities | — | $7.5M | $5.5M |
| Inventory | — | $0.6M | $0.5M |
| Property and equipment, net | — | $2.4M | $2.2M |
| Intangible assets | — | $0.7M | $0.6M |
| Total assets | — | $7.1M | $7.0M |
| Total liabilities | — | $8.2M | $10.2M |
| Shareholders' equity | $1.5M | −$0.9M | −$2.9M |
| Margins | |||
| Gross margin | 24.9% | 38.6% | 32.1% |
| Operating margin | −98.0% | −73.6% | −41.8% |
| Net margin | −95.9% | −74.6% | −41.4% |
| FCF margin | −66.1% | −50.2% | −54.2% |
| Returns | |||
| Return on capital employed | — | 696.7% | −136.0% |
| Return on equity | −158.8% | −893.9% | — |
| Return on assets | — | −35.2% | −28.5% |
| Return on tangible equity | −158.8% | — | — |
| Growth | |||
| Revenue growth | — | 40.2% | 44.1% |
| Share count change | — | 0.0% | 1.5% |
| Financial health | |||
| Interest coverage | −55.0x | −51.4x | −40.2x |
| Current ratio | — | 0.2x | 0.4x |
| Quick ratio | — | 0.1x | 0.3x |
| Capital allocation | |||
| Capex / revenue | 9.2% | 2.5% | 1.2% |
| Quality scores | |||
| Piotroski F-score | — | — | 3.0 |
| Altman Z'' | — | −13.1 | −11.7 |
| Accruals ratio | — | −12.7% | 8.0% |
Source: SEC EDGAR XBRL filings (CIK 0002025774). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.